Skip to main content
Chong Kun Dang Pharmaceutical Corp. logo

Chong Kun Dang Pharmaceutical Corp. — Investor Relations & Filings

Ticker · 185750 ISIN · KR7185750007 KO Manufacturing
Open in API
Filings indexed 420 across all filing types
Latest filing 2026-04-30 Regulatory Filings
Country KR South Korea
Listing KO 185750

About Chong Kun Dang Pharmaceutical Corp.

https://www.ckdpharm.com

Chong Kun Dang Pharmaceutical Corp. is a pharmaceutical company focused on the research, development, manufacturing, and commercialization of a broad range of medicines. Its portfolio encompasses prescription drugs, over-the-counter (OTC) products, and health supplements. The company is committed to innovation, with significant investment in R&D to develop novel treatments. Key therapeutic areas of focus include systemic anti-infectives and metabolic diseases. Through a robust pipeline and extensive clinical trials, the company develops quality medicines to improve public health and quality of life.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Regulatory Filings
2026-04-30 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 1% confidence The document is a summary table of provisional (잠정) quarterly business results for Q1 2026 (영업(잠정)실적), including key metrics like sales, operating profit, and net income, presented under fair disclosure rules. It provides initial highlights of the period’s financial performance, not a full interim report or annual filing. This aligns with an Earnings Release (ER). Q1 2026
2026-04-29 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a statutory ‘주식등의 대량보유상황보고서(일반)’ (large shareholding report) filed under the Capital Markets Act, detailing share counts, percentages, change reasons, insider relationships and thresholds. It is not an earnings release, management commentary or AGM material but a notification of significant share ownership changes. This aligns exactly with a Major Shareholding Notification (Code: MRQ).
2026-04-21 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a ‘주식등의 대량보유상황보고서(일반)’ under Korea’s Capital Markets Act Article 147, detailing large shareholdings and related parties. It is a regulatory submission of a major shareholding notification rather than an earnings release or management commentary. This corresponds to the ‘Major Shareholding Notification’ category.
2026-04-07 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a “주식등의 대량보유상황보고서(일반)” filing under Korea’s Capital Markets Act, detailing the number of shares and voting rights held by the reporting person and special related parties, changes in holdings, thresholds crossed, and purpose of holdings. This is a mandatory notification of substantial share ownership changes. It exactly matches the “Major Shareholding Notification” category.
2026-04-02 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled “정기주주총회결과” (Regular Shareholders’ Meeting Results) and provides detailed approval outcomes for each agenda item (financial statements approval, dividend resolution, director/auditor appointments, amendments to the articles, voting percentages, etc.). This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-03-26 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.